secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001104659-25-051336
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharma receives Nasdaq delisting notice; trading to move to OTC Markets
------------------------------------------------------------------------------

- Delisting due to failing minimum equity, bid price ($1.00), and public interest concerns from Feb 2025 offering.
- Trading suspended on Nasdaq at open May 22, 2025; expected to trade on OTC Markets under PTPI.
- Company has 15 days to appeal to Nasdaq Listing Council; appeal stays Form 25 but not suspension.
- No assurance that Listing Council will grant continued listing on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465925051336/0001104659-25-051336-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465925051336/tm2515781d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-051336

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer